Intuitive Surgical, Inc. $ISRG Shares Acquired by CENTRAL TRUST Co

CENTRAL TRUST Co boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,828 shares of the medical equipment provider’s stock after purchasing an additional 137 shares during the quarter. CENTRAL TRUST Co’s holdings in Intuitive Surgical were worth $1,537,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of ISRG. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after acquiring an additional 453,335 shares during the last quarter. Invesco Ltd. increased its stake in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after acquiring an additional 71,794 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP lifted its stake in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $1,715,899,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 101,683 shares of company stock worth $53,517,192 over the last ninety days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

Shares of NASDAQ ISRG opened at $572.45 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The business has a 50 day moving average price of $478.64 and a two-hundred day moving average price of $502.49. The firm has a market cap of $205.21 billion, a PE ratio of 75.72, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the prior year, the business posted $1.84 EPS. The business’s revenue was up 22.9% on a year-over-year basis. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Piper Sandler raised their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. HSBC increased their price target on Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, BTIG Research boosted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.